Aisling O'Loughlin, Ph.D
Advertisement

Aisling O'Loughlin, Ph.D., is a Principal at IQVIA working at the intersection of AI, innovation and strategy consulting. She leads AI and advanced analytics engagements, applying algorithms along the patient journey and across the asset lifecycle to draw meaningful value from data, and pairs big data, models and bespoke technology with human expertise to support better-informed, faster decisions. She holds a doctorate in gene therapy and neuroscience and an MSc in neuroscience from the University of Oxford, and a BSc in neuroscience and pharmacology from University College Dublin.
Articles by Aisling O'Loughlin, Ph.D
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner
2
How Elevated Cortisol Levels Can Impact Type II Diabetes Treatments
3
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
4
IBD's Most Persistent Gap: Q&A with Christian Thienel
5